Clinical Trial Results

Condition: Breast Cancer Location: Santa Fe, New Mexico 5 trials found

Caris Biorepository Research Protocol

N/AOBSERVATIONAL Mobile, Alabama +4 more

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

PHASE3INTERVENTIONAL Mobile, Alabama +4 more

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

PHASE3INTERVENTIONAL Jonesboro, Arkansas +4 more

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

PHASE3INTERVENTIONAL Hot Springs, Arkansas +4 more